NASDAQ:RCKT | Free Cash Flow | ROCKET PHARMACEUTICALS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2014-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$45.39M$93,000.00-$45.49M
2025-12-31-$34.84M$80,000.00-$34.92M
2025-03-31-$55.79M$364,000.00-$56.15M
2024-12-31-$46.94M$309,000.00-$47.25M
2024-03-31-$56.86M$2.04M-$58.89M
2023-12-31-$29.34M$4.65M-$33.99M
2023-03-31-$57.56M$3.02M-$60.58M
2022-12-31-$56.02M$3M-$59.02M
2022-03-31-$39.22M$1.96M-$41.18M
2021-12-31-$30.94M$1.97M-$32.91M
2021-03-31-$24.28M$328,000.00-$24.61M
2020-12-31-$13.11M$13.65M-$26.76M
2020-03-31-$22.25M$5.21M-$27.45M
2019-12-31-$19.73M$9.25M-$28.99M
2019-03-31-$15.98M$760,000.00-$16.74M
2018-12-31-$20.81M$883,000.00-$21.7M
2018-03-31-$11.6M$8,000.00-$11.61M
2017-12-31-$5.99M$30,000.00-$6.02M
2017-03-31-$3.72M$131,000.00-$3.85M
2016-12-31$20.63M
2016-03-31-$8.99M
2015-12-31-$7.04M
2015-03-31-$1.99M
2014-12-31-$2.99M
2014-03-31-$1.86M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$190.01M$440,000.00-$190.45M
2024-12-31-$209.72M$5.86M-$215.59M
2023-12-31-$194.92M$16.44M-$211.35M
2022-12-31-$178.14M$8.36M-$186.5M
2021-12-31-$121.16M$7.62M-$128.78M
2020-12-31-$74.64M$20.61M-$95.25M
2019-12-31-$64.66M$23.27M-$87.93M
2018-12-31-$53.79M$1.45M-$55.24M
2017-12-31-$15.96M$760,000.00-$16.72M
2016-12-31-$5.5M$335,000.00-$5.84M
2015-12-31-$17.42M
2014-12-31-$9.74M